After decades of surgical practice and countless hours spent at the bedside of patients with complex, chronic conditions, a fundamental question has persisted: Why do two patients with identical diagnoses, receiving identical treatments, experience such radically different outcomes? Why does one patient's cancer respond to therapy while another's progresses relentlessly? Why does one person with autoimmune disease achieve remission while another suffers through decades of debilitating flares?

The answer has been hiding in plain sight — not in any single organ, not in any isolated molecular pathway, but in the dynamic, bidirectional conversation between the mind, the nervous system, the endocrine system, and the immune system.

This is the domain of Psycho-Neuro-Endocrino-Immunology (PNEI) — also known as Psychoneuroimmunology (PNI) — an interdisciplinary field that studies the intricate interactions between psychological processes, the nervous system, the endocrine system, and the immune system. As articulated in the 2025 systemic paradigm for PNEI, this framework describes the reciprocal relationships between the psyche and biological systems, and between the entire organism and its physical and social environment.

PNEI is not merely an academic curiosity. It is a revolutionary framework that is fundamentally reshaping how we understand, prevent, and treat the most challenging diseases of our time — from cancer and autoimmune disorders to neurodegenerative diseases and metabolic syndrome. As a 2025 review in Biological Psychiatry noted, psychoneuroimmunoendocrinology (PNIE) offers a framework to explore complex interactions between the psyche and the nervous, immune, and endocrine systems.

This article presents a comprehensive exploration of PNEI — its scientific foundations, its clinical applications across major disease categories, and its transformative potential for the future of medicine.

The Science of Connection — How the Mind and Body Speak the Same Language

The End of the Cartesian Divide

For centuries, Western medicine has operated under a Cartesian dualism that separated the mind from the body. The brain was the seat of consciousness; the immune system was a self-contained defence network; the endocrine system regulated metabolism independently. Diseases were classified as either "physical" or "mental," and treatment was siloed accordingly.

PNEI has definitively ended this conceptual divide. As Francesco Bottaccioli and Anna Giulia Bottaccioli argued in their 2025 paper establishing a systemic and dialectical paradigm for PNEI, the field demonstrates the "scientific inconsistency of the reductionist dogma that makes the psyche a mere epiphenomenon of brain activity". The human being cannot be understood as a collection of separate systems — it is an integrated whole in which psychological, neurological, endocrine, and immune processes are in constant, bidirectional communication.

The Communication Superhighway

The PNEI framework identifies multiple interconnected pathways through which the mind influences the body and vice versa:

The Hypothalamic-Pituitary-Adrenal (HPA) Axis: Psychological stress activates the hypothalamus, which signals the pituitary gland to release adrenocorticotropic hormone (ACTH), which in turn stimulates the adrenal glands to produce cortisol. Chronic stress leads to persistent cortisol elevation, which suppresses immune function and promotes systemic inflammation.

The Sympathetic Nervous System: Stress activates the sympathetic nervous system, releasing catecholamines (adrenaline and noradrenaline) that directly influence immune cell function. Chronic sympathetic activation promotes a pro-inflammatory state that underlies numerous chronic diseases.

The Microbiota-Gut-Brain Axis: The gut microbiome communicates bidirectionally with the brain through neural, endocrine, and immune pathways. Disruptions in gut microbiota have been implicated in neuroinflammation, mood disorders, and systemic inflammation.

The Heart-Brain Axis: Bidirectional communication between the heart and the brain influences emotional regulation, stress responses, and immune function.

Neuroinflammation: Chronic activation of the brain's immune cells (microglia) contributes to neurodegenerative diseases, mood disorders, and cognitive decline.

The Neuroendocrine-Immune Network: The endocrine and immune systems communicate through shared signalling molecules — cytokines, hormones, and neurotransmitters — creating a dynamic, self-regulating network that maintains homeostasis.

The Cytokine Network and "Metaflammation"

Recent advancements in PNEI research have revealed that numerous noncommunicable diseases (NCDs) originate from disruptions in the cytokine immune network, resulting in chronic inflammatory responses. This persistent low-grade inflammation, termed "metaflammation" (metabolic inflammation), is increasingly recognized as the common soil from which many chronic diseases arise.

Crucially, this chronic inflammation is attributed to deficiencies in crucial endogenous anti-inflammatory neuroendocrine systems, including the pineal gland (melatonin and related hormones), the endocannabinoid system, and the angiotensin-converting enzyme 2 (ACE2) / angiotensin 1-7 axis. As one 2025 study observed, pineal hormones, endocannabinoids, and Ang 1-7 act as fundamental anti-inflammatory molecules provided by the human body, "completely devoid of any toxicity".

The separation between experimental and clinical medicine has become "dramatic" because the diagnosis and therapy of endocrine, nervous, and immune pathologies continue to be separately performed, despite the physiological impossibility of separating these systems in vivo. PNEI offers a path to reintegrate these systems in both research and clinical practice.

PNEI and Cancer — The Neuroimmune Dimension of Oncogenesis

The Immune Surveillance Failure

Cancer has traditionally been understood as a disease of uncontrolled cellular proliferation driven by genetic mutations. While this remains fundamentally correct, the PNEI framework reveals a critical additional dimension: cancer progression is profoundly influenced by the neuroendocrine-immune environment in which it develops.

A 2025 clinical study evaluating a neuroimmune regimen in 306 patients with noncommunicable diseases — including advanced cancer, autoimmune diseases, neurodegenerative disorders, depression, and cardiovascular disease — demonstrated that the neuroimmune regimen successfully halted cancer progression in 68% of cancer patients, who also reported improvements in mood, sleep, and relief from anxiety, pain, and fatigue.

The regimen comprised:

· Melatonin (100 mg/day at night) — the primary pineal hormone with potent anti-inflammatory and anti-tumour properties

· 5-Methoxytryptamine (30 mg in the early afternoon) — another pineal methoxyindole with immunomodulatory effects

· Angiotensin 1-7 (0.5 mg twice daily) — the ACE2-derived peptide with anti-inflammatory and anti-proliferative activity

· Cannabidiol (20 mg twice daily) — the non-psychoactive cannabinoid with broad anti-inflammatory effects

The Pineal-Immune Connection

The pineal gland has emerged as a critical node in the neuroimmune regulation of cancer. Pineal hormones, particularly melatonin, exhibit:

· Direct anti-proliferative effects on cancer cells

· Immunostimulatory effects on natural killer (NK) cells and T lymphocytes

· Anti-inflammatory effects through inhibition of pro-inflammatory cytokines

· Antioxidant effects that protect against oxidative DNA damage

The progressive decline in endogenous production of pineal hormones, endocannabinoids, and Ang 1-7 that occurs with aging and chronic disease contributes to "a consequent inflammatory status and diminished natural resistance against cancer". This suggests that neuroimmune decline is not merely a consequence of disease but a driver of disease progression.

Clinical Implications for Oncology

The PNEI framework suggests that comprehensive cancer care must include:

· Assessment of neuroendocrine-immune status — including pineal function, endocannabinoid system activity, and inflammatory markers

· Neuroimmune support — including appropriate use of melatonin, cannabinoids, and other neuroimmune modulators

· Stress reduction — psychological interventions to reduce cortisol-mediated immune suppression

· Sleep optimisation — recognising that melatonin production is critically dependent on sleep quality

· Nutritional support — addressing the dietary factors that influence neuroendocrine-immune function

PNEI and Autoimmune Disease — Restoring Immune Tolerance

The Breakdown of Self-Recognition

Autoimmune diseases — from multiple sclerosis and rheumatoid arthritis to lupus and Hashimoto's thyroiditis — represent a fundamental failure of immune self-tolerance. The immune system, instead of protecting the body, attacks its own tissues.

The PNEI framework reveals that autoimmune disease is not simply a failure of immune regulation but a systemic breakdown involving the nervous and endocrine systems. Stress, hormonal imbalances, and neuroinflammation all contribute to the loss of immune tolerance.

Clinical Evidence

The same 2025 neuroimmune study that demonstrated efficacy in cancer also showed remarkable results in autoimmune diseases: "In patients with autoimmune diseases, the treatment effectively controlled the disease process, remarkable in cases of multiple sclerosis".

A 2025 randomised controlled trial published in Psychoneuroendocrinology demonstrated the psychological and immunological benefits of Eye Movement Desensitization and Reprocessing (EMDR) in Hashimoto's thyroiditis, providing preliminary evidence that psychological interventions can directly influence autoimmune disease activity.

The Stress-Autoimmunity Connection

Psychological stress is a well-established trigger for autoimmune flares. The mechanisms involve:

· HPA axis dysregulation — leading to abnormal cortisol responses

· Sympathetic nervous system activation — promoting pro-inflammatory cytokine production

· Microbiota-gut-brain axis disruption — altering immune regulation through the gut microbiome

· Neuroinflammation — activating microglia that contribute to tissue-specific autoimmune responses

Integrative Management

The PNEI framework advocates for integrative management of autoimmune diseases that combines:

· Pharmacological immunosuppression — where indicated

· Stress reduction interventions — mindfulness, cognitive-behavioural therapy, and relaxation techniques

· Sleep optimisation — recognising the role of sleep in immune regulation

· Dietary interventions — addressing gut health and inflammation

· Neuroimmune modulation — including appropriate use of melatonin, cannabinoids, and other neuroimmune agents

· Physical activity — with recognition of its immunomodulatory effects

PNEI and Neurodegenerative Disease — The Inflammation Connection

The Role of Neuroinflammation

Neurodegenerative diseases — Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis (ALS), and others — have traditionally been understood through the lens of protein aggregation: amyloid plaques, tau tangles, and alpha-synuclein aggregates. The PNEI framework adds a critical dimension: neuroinflammation is not merely a consequence of neurodegeneration but a driver of disease progression.

The gut microbiota is a key player in modulating neuroinflammation, a critical pathological feature of Alzheimer's disease. The role of the gut microbiota in this process is essential for uncovering new therapeutic avenues and gaining deeper insights into AD pathogenesis.

Clinical Evidence

In the 2025 neuroimmune study, "positive outcomes were observed in patients with Parkinson's disease, Alzheimer's disease, and depression". The neuroimmune regimen, by targeting the inflammatory network that underlies these conditions, demonstrated the potential to modify disease progression rather than merely managing symptoms.

A 2025 review integrating multi-omics approaches with PNEI provided a detailed framework linking psychoneuroimmunological pathways to multiple sclerosis pathology. This integrative approach highlights the importance of stress-related pathways in MS pathogenesis, suggesting that stress management and neuroimmune support should be integral components of MS care.

The Microbiota-Neuroinflammation Axis

The gut microbiome influences brain health through multiple mechanisms:

· Production of neuroactive metabolites — including short-chain fatty acids, neurotransmitters, and tryptophan metabolites

· Regulation of systemic inflammation — through effects on gut permeability and immune cell trafficking

· Modulation of the vagus nerve — providing a direct neural pathway from the gut to the brain

· Influence on the HPA axis — through effects on stress hormone regulation

Therapeutic Implications

The PNEI framework suggests that neurodegenerative disease management should include:

· Neuroimmune support — including appropriate neuroendocrine agents

· Gut microbiome optimisation — through diet, probiotics, and prebiotics

· Stress reduction — to reduce cortisol-mediated neuroinflammation

· Sleep optimisation — to support glymphatic clearance and pineal function

· Physical activity — to promote neuroplasticity and reduce inflammation

PNEI and Psychiatric Disorders — Beyond the Neurotransmitter Model

The Inadequacy of Reductionism

For decades, psychiatric disorders have been understood primarily through the lens of neurotransmitter imbalances — serotonin, dopamine, noradrenaline. While this model has yielded effective pharmacotherapies, it has also proven inadequate for many patients, who continue to struggle despite optimal medication management.

A 2025 paper rethinking depression through a PNEI framework demonstrated the "inadequacy of the reductionist paradigm" and illustrated the "superiority of the systemic paradigm centered on psychoneuroendocrineimmunology (PNEI)".

PTSD: A Case Study in PNEI

Posttraumatic stress disorder (PTSD) provides a compelling example of the PNEI framework in action. PTSD affects 5% to 10% of the population, with increased prevalence among women and individuals in war zones. Beyond psychological symptoms, PTSD induces significant physiological changes across systems.

Studies have revealed that PTSD entails disruptions in the central and autonomic nervous, immune, and endocrine systems, including gut microbiota imbalances, which impair organ function. Integrative pathways that connect these parts include:

· The microbiota-gut-brain axis — linking gut health to brain function

· The heart-brain axis — connecting cardiac function to emotional regulation

· Neuroinflammation — contributing to cognitive and mood symptoms

· Hypothalamic-pituitary dysregulation — disrupting stress hormone responses

These findings highlight "bidirectional links between mental and physical health". Viewing PTSD as an entity comprising both psychological and physiological challenges underscores the importance of integrative care strategies that combine pharmacological treatments, psychotherapy, and lifestyle interventions.

Implications for Psychiatric Care

The PNEI framework suggests that psychiatric care should be:

· Integrative — combining pharmacotherapy with psychological, lifestyle, and neuroimmune interventions

· Personalised — tailored to the individual's specific neuroendocrine-immune profile

· Biomarker-informed — using immunological and endocrine markers to guide treatment selection

· Holistic — addressing sleep, nutrition, physical activity, and social connections alongside symptom management

PNEI and Metabolic Disease — The Obesity-Inflammation Connection

The PNI Dysfunction in Obesity

Obesity, a condition of increasing global prevalence, is associated with elevated risk of PNI dysfunction. The PNI framework integrates the disciplines of psychology, neuroscience, and immunology to probe the interactions between thoughts, neurology, and immunity.

Obesity is associated with numerous PNI-related sequelae, including:

· Increased levels of psychological distress

· Cognitive deficits

· Dysautonomia (autonomic nervous system dysfunction)

· Immune system abnormalities

A 2026 pilot study assessed the feasibility of a PNI-focused assessment battery in combination with community-based chiropractic care in adults with obesity. The results indicated that self-reported autonomic nervous system functioning and perceived stress levels demonstrated the largest within-group improvements among the PNI-related outcomes assessed. A future definitive controlled trial is planned to investigate the efficacy of chiropractic care on PNI-related outcomes in adults with obesity.

The Metabolic-Inflammatory Axis

Obesity drives systemic inflammation through multiple mechanisms:

· Adipose tissue dysfunction — leading to increased production of pro-inflammatory cytokines

· Gut microbiome alterations — contributing to increased intestinal permeability and endotoxemia

· HPA axis dysregulation — promoting cortisol-mediated inflammation

· Sympathetic nervous system activation — driving catecholamine-mediated immune effects

Therapeutic Implications

The PNI framework suggests that obesity management should include:

· Psychological support — addressing stress, emotional eating, and mental health

· Neurological assessment — evaluating autonomic function and stress responses

· Immunological monitoring — tracking inflammatory markers

· Integrative interventions — combining lifestyle, psychological, and neuroimmune approaches

The Future of PNEI — A New Paradigm for Medicine

The Systemic Paradigm

PNEI represents more than a scientific discipline — it is a new paradigm for medicine. As articulated by Bottaccioli and Bottaccioli, "integrated care needs a philosophical paradigm. Psychoneuroendocrinoimmunology can be this, provided that consensus is created on its profound meaning".

The systemic paradigm of PNEI views the human being as an integrated whole, in constant dialogue with the physical and social environment. It moves beyond the reductionist model that has dominated medicine for centuries, recognising that health and disease emerge from the dynamic interactions between psychological, neurological, endocrine, and immune processes.

The One Health Connection

The PNEI paradigm aligns with the broader concept of "One Health" — the recognition that human health is inseparable from the health of the ecosystems in which we live. Several new paradigms of care and research arise from this vision, "the most important to date is the PNEI Paradigm".

Clinical Integration

The integration of PNEI into clinical practice is already underway. Italian universities are now teaching PNEI as part of medical education. A learning module at the University of Milan aims to provide students with a comprehensive understanding of the integration between medical practice and the PNEI approach, applying PNEI concepts to interpret clinical data and develop integrative therapeutic strategies for metabolic and oncological diseases.

The Neuroimmune Therapy Revolution

The 2025 neuroimmune study represents a landmark in the clinical application of PNEI. The regimen comprising pineal methoxyindoles (melatonin, 5-methoxytryptamine), cannabinoids, and angiotensin 1-7 demonstrates the potential to address the fundamental neuroimmune dysregulation that underlies multiple NCDs.

The study concluded that "randomized controlled trials are required to assess this therapeutic approach for NCDs that includes endogenous neuroendocrine molecules regulating immune responses in an anti-inflammatory manner". This call for rigorous clinical evaluation represents the next frontier in PNEI research.

The Personalised Medicine Dimension

PNEI is inherently personalised. The evaluation of the functional status of the pineal gland, the endocannabinoid system, and the ACE2-Ang 1-7 axis "should have to be included within the laboratory analyses for the systemic diseases". This recognises that individual variations in neuroendocrine-immune function profoundly influence disease susceptibility, progression, and treatment response.

The Research Frontier

The research frontier of PNEI includes:

· Multi-omics integration — linking PNEI to genomics, proteomics, and metabolomics

· Biomarker development — identifying neuroimmune markers for diagnosis and treatment monitoring

· Clinical trials — rigorous evaluation of neuroimmune interventions

· Mechanistic studies — elucidating the molecular pathways underlying mind-body interactions

Conclusion: The Master Regulator

PNEI is not a fringe discipline or an alternative therapy. It is a rigorous, evidence-based scientific framework that reveals the fundamental interconnectedness of the mind, the nervous system, the endocrine system, and the immune system. It demonstrates that health and disease cannot be understood in isolation — they emerge from the dynamic, bidirectional communication between these systems.

The clinical evidence is compelling. A neuroimmune regimen targeting pineal hormones, endocannabinoids, and the ACE2-Ang 1-7 axis has halted cancer progression in 68% of patients, controlled disease in autoimmune conditions, and produced positive outcomes in neurodegenerative diseases and depression. Psychological interventions have demonstrated immunological benefits in autoimmune disease. The PNEI framework has provided new insights into the pathophysiology of PTSD, obesity, and other conditions.

The implications for clinical practice are profound. Physicians must move beyond the siloed approach that treats the mind, the nervous system, the endocrine system, and the immune system as separate domains. They must recognise that psychological states influence immune function, that hormonal balance affects neurological health, and that immune activation shapes mood and cognition.

The future of medicine lies in the integration of PNEI principles into routine clinical practice — in oncology, autoimmunology, neurology, psychiatry, and metabolic medicine. It lies in the recognition that the master regulator of health is not any single system but the dynamic, integrated network that connects them all.

The reductionist era of medicine is ending. The era of systemic, integrative, PNEI-informed medicine has begun.

The mind and body are not separate systems — they are a single, integrated network. Psycho-Neuro-Endocrino-Immunology (PNEI) reveals the master regulator of health: the bidirectional communication between psychology, neurology, endocrinology, and immunology. The future of medicine is not siloed. It is systemic. Read the full article. #PNEI #Psychoneuroimmunology #MindBodyMedicine #Neuroimmune #IntegrativeMedicine #ChronicDisease #Neuroendocrine #SystemicMedicine #FutureOfMedicine

References

1. Bottaccioli F, Bottaccioli AG. A systemic and dialectical paradigm for Psychoneuroendocrineimmunology and integrated care science. Brain Behavior and Immunity Integrative. 2025;12:100138.

2. Lissoni P, Rovelli F, Monzon A, et al. Efficacy of a Neuroimmune Therapy Including Pineal Methoxyindoles, Angiotensin 1-7, and Endocannabinoids in Cancer, Autoimmune, and Neurodegenerative Diseases. Clinical Interventions in Aging. 2025;20:513-522.

3. Fraile-Martinez O, García-Montero C, Álvarez-Mon MÁ, et al. Grasping Posttraumatic Stress Disorder From the Perspective of Psychoneuroimmunoendocrinology: Etiopathogenic Mechanisms and Relevance for Integrative Management. Biological Psychiatry. 2025;98(10):733-745.

4. Lissoni P, et al. Psycho-Neuro-EndocrinE-Immunology Therapy of Cancer, Autoimmunity, Geriatric Disorders, Covid-19, and Hypertension. Methods in Molecular Biology. 2025. PMID: 39546228.

5. Pérez TM, Sliwka M, Smith-Ireland D, et al. Psychoneuroimmunological changes in adults with obesity receiving chiropractic care: a single-arm pilot trial. Frontiers in Psychiatry. 2026;17:1846987.

6. Psychological and immunological benefits of eye movement desensitization and reprocessing in Hashimoto thyroiditis: Preliminary findings from a randomized controlled trial. Psychoneuroendocrinology. 2025.

7. Islam N, et al. Investigating molecular background of multiple sclerosis through multi-omics: linking via psychoneuroimmunology. Acta Neurologica Belgica. 2025;125(5):1357-1371.

8. Psychoneuroimmunology (PNI) is an interdisciplinary field of study that provides the scientific and empirical basis for personalized healthcare system. ScienceDirect. 2026.

9. Psychoneuroendocrinoimmunology (PNEI) is an interdisciplinary field that studies the interactions between psychological processes, the nervous system, the endocrine system, and the immune system. Academia.edu. 2025.

10. A Comprehensive Review of Experimental Models of Stress: Pragmatic Insight Into Psychoneuroimmunology. PubMed. 2025

How Psycho-Neuro-Endocrino-Immunology (PNEI) Is Rewriting the Future of Medicine

The Unspoken Truth at the Heart of Chronic Disease